Avacta Annual General Meeting and Shareholder Event Detailed Agenda
Avacta Annual General Meeting and Shareholder Event Detailed Agenda
Chill Brands Group (CHLL), the international consumer packaged goods company, provided an update on arrangements for the planned sale of its nicotine-free vapour products to US consumers via the Chill.com
Avacta Achieves Second Milestone in AffyXell Joint Venture Triggering Increased Equity Stake
Avacta Group plc (AIM: AVCT), a life sciences company developing innovative, targeted oncology drugs and powerful diagnostics, today announces that its Annual Report and Accounts for the year ended 31 December
ENGAGE XR Holdings (EXR), a metaverse technology company, announce that, further to the announcement made on 28 September 2022, Lenovo™â€™s new ThinkReality™ VRX all-in-one virtual reality (VR) headset engineered for
Avacta Group plc, a life sciences company that develops targeted oncology drugs and diagnostics, has dosed the first patient in the US as part of its phase 1 multi-center trial
This post was written by Zak Mir, a Technical Analyst, Events Host, Presenter, CEO Interviewer and established Market Commentator.
A period of continued significant progress
Overall, the AIM All-Shares Index closed the week down by half a percent, underperforming against the FTSE 100 and FTSE 350 indices, which both closed around half a percent higher.
Avacta Presents AVA3996 Pre-clinical Data at the American Association for Cancer Research Meeting
Overall, the AIM All-Shares index had a positive week, with a more than 2% increase in share price, outperforming the FTSE 100. Friday’s closing bell, the FTSE 100 resumed its